APA

Rehman H., Ramshesh V. K., Theruvath T. P., Kim I., Currin R. T., Giri S., Lemasters J. J. & Zhong Z. (20090105). NIM811 (N-methyl-4-isoleucine cyclosporine), a mitochondrial permeability transition inhibitor, attenuates cholestatic liver injury but not fibrosis in mice. : The Journal of pharmacology and experimental therapeutics.

Chicago

Rehman Hasibur, Ramshesh Venkat K, Theruvath Tom P, Kim Insil, Currin Robert T, Giri Shailendra, Lemasters John J and Zhong Zhi. 20090105. NIM811 (N-methyl-4-isoleucine cyclosporine), a mitochondrial permeability transition inhibitor, attenuates cholestatic liver injury but not fibrosis in mice. : The Journal of pharmacology and experimental therapeutics.

Harvard

Rehman H., Ramshesh V. K., Theruvath T. P., Kim I., Currin R. T., Giri S., Lemasters J. J. and Zhong Z. (20090105). NIM811 (N-methyl-4-isoleucine cyclosporine), a mitochondrial permeability transition inhibitor, attenuates cholestatic liver injury but not fibrosis in mice. : The Journal of pharmacology and experimental therapeutics.

MLA

Rehman Hasibur, Ramshesh Venkat K, Theruvath Tom P, Kim Insil, Currin Robert T, Giri Shailendra, Lemasters John J and Zhong Zhi. NIM811 (N-methyl-4-isoleucine cyclosporine), a mitochondrial permeability transition inhibitor, attenuates cholestatic liver injury but not fibrosis in mice. : The Journal of pharmacology and experimental therapeutics. 20090105.